Janux Therapeutics, Inc. (NASDAQ:JANX)是一家市值26.9亿美元的生物科技公司,其总裁兼首席执行官David Alan Campbell最近出售了5,000股公司普通股。这笔交易发生在2025年1月7日,是根据Campbell于2024年6月21日采用的预先安排的Rule 10b5-1交易计划进行的。该公司股票表现出色,过去一年的回报率达364%。
The Dec 23 article in The New York Times, titled "US Takes Aim at China's Production of Essential Computer Chips", drew numerous comments from readers — some of whom agreed with the government and ...
China’s state economic planner asked all local governments to act under the same standards to eliminate cross-regional restrictions in market entry, aiming to accelerate their integration into the ...